A prospective randomized study on the effects of clinical use of hyaluronic acid in patients with ankle osteoarthritis lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008690

Enrollment

Registered

2023-08-08

Start date

2019-12-24

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : A standard sterile skin preparation technique was performed around the ankle joint, and intra-articular injection was performed medial to the tibialis anterior tendon in the same location used

2 mL, Hyruan Plus®

LG Life Sciences, Iksan, Korea) and 3 ml of mixture including 1 ml of corticosteroid (2.5 mg/ml, Triam®, ShinPoong Pharmaceuticals, Seoul, Korea), 1 ml of 0.5% bupivacaine (bupivacaine HCl®, Hana Phar

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A person diagnosed with ankle arthritis Adults aged 19 years or older who can express their opinions Person who consented to this study

Exclusion criteria

Exclusion criteria: Those with existing musculoskeletal disorders A person who cannot perform injection treatment or who refuses treatment Those who are pregnant or breastfeeding

Design outcomes

Primary

Measure	Time frame
The Ankle Osteoarthritis Scale (AOS)	—

Secondary

Measure	Time frame
Visual analog scale;Side effects related injection	—

Countries

Korea, Republic of

Contacts

Public ContactChul Hyun Park

Yeongnam University Medical Center

chpark77@naver.com+82-53-620-3620

Outcome results